I
IMNM
Immunome Inc
28.75
-0.64-2.16%Pre Market: 28.90 +0.15 +0.52%07:04 08/27 EDT
OPEN/PREV CLOSE29.34/29.39
TODAY RANGE28.62-29.39
VOL6
MARKET CAP3.27B
52 WEEK RANGE8.67-30.06
AVG VOL (3M)1.40M
% TURNOVER0.49%
TURNOVER0
P/E (TTM)-11.4496
% RANGE2.60%
EPS(TTM)-2.5110
P/E(FORWARD)-12.0272
P/B6.21
BVPS4.630
DIVIDEND--
P/S468.24
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.05B
SHARES OUTSTANDING113.58M
NEXT EARNINGS11/04-11/09
FREE FLOAT106.00M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/17 09:43
Immunome price target raised to $35 from $31 at Wedbush
Seeking Alpha·08/13 19:24
Immunome: Maintaining My 'Strong Buy' Rating With 2 Catalysts On The Horizon
TipRanks·08/13 11:18
Immunome (IMNM) Receives a Buy from Guggenheim
Dow Jones·08/12 17:37
Immunome Is Maintained at Buy by Truist Securities
Dow Jones·08/12 17:37
Immunome Price Target Raised to $38.00/Share From $37.00 by Truist Securities
Benzinga·08/12 17:27
Truist Securities Maintains Buy on Immunome, Raises Price Target to $38
Dow Jones·08/12 16:19
Immunome Price Target Raised to $35.00/Share From $31.00 by Wedbush
Dow Jones·08/12 16:19
Immunome Is Maintained at Outperform by Wedbush
Benzinga·08/12 16:09
Wedbush Maintains Outperform on Immunome, Raises Price Target to $35
TipRanks·08/12 14:05
Wedbush Sticks to Their Buy Rating for Immunome (IMNM)
TipRanks·08/12 13:46
Evercore ISI Remains a Buy on Immunome (IMNM)
TipRanks·08/12 11:07
Piper Sandler Keeps Their Buy Rating on Immunome (IMNM)
Same Industry
Name/Symbol
Change%
Price